The Accelerated Drug Approval

[1] Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) : 479 - 489

[2] Kaufman Brian, 2003, Ocul Surf, V1, P80

[3] Orphan drugs [J]. OCULAR SURFACE, 2008, 6 (01) : 52 - 55

[4] Just a Small, Proof-of-Concept Study [J]. OCULAR SURFACE, 2009, 7 (02) : 111 - 112

[5] The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (04) : 1497 - 1505

[1] Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (02) : 479 - 489

[2] Kaufman Brian, 2003, Ocul Surf, V1, P80

[3] Orphan drugs [J]. OCULAR SURFACE, 2008, 6 (01) : 52 - 55

[4] Just a Small, Proof-of-Concept Study [J]. OCULAR SURFACE, 2009, 7 (02) : 111 - 112

[5] The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (04) : 1497 - 1505